Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Bromoalkoxyxanthones as promising antitumor agents: Synthesis, crystal structure and effect on human tumor cell lines
Publication

Publications

Bromoalkoxyxanthones as promising antitumor agents: Synthesis, crystal structure and effect on human tumor cell lines

Title
Bromoalkoxyxanthones as promising antitumor agents: Synthesis, crystal structure and effect on human tumor cell lines
Type
Article in International Scientific Journal
Year
2009
Authors
Emilia Sousa
(Author)
FFUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Ana Paiva
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Nair Nazareth
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Luis Gales
(Author)
ICBAS
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Ana M Damas
(Author)
ICBAS
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Madalena Pinto
(Author)
FFUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Journal
Vol. 44 No. 5
Pages: 3830-3835
ISSN: 0223-5234
Publisher: Elsevier
Indexing
Scientific classification
FOS: Medical and Health sciences > Basic medicine
Other information
Authenticus ID: P-003-G2R
Abstract (EN): In a study involving the synthesis of bis-intercalators, a bisxanthone and a minor product, 1-(6-bromohexyloxy)-xanthone were obtained. Although no capacity to inhibit the growth of human tumor cell lines was observed for the bisxanthone, the bromoalkoxyxanthone revealed this biological activity. In light of these results bromoalkylation of 3,4-dihydroxyxanthone furnished two bromohexyloxyxanthones that were investigated for their effect on the in vitro growth of human tumor cell lines MCF-7 (ER+, breast), MDA-MB-231 (ER-, breast), NCI-H460 (non-small lung), and SF-268 (central nervous system). The X-ray structure of 1-(6-bromohexyloxy)-xanthone revealed that the xanthone skeleton remains essentially planar forming a dihedral angle of 61.3(2)degrees with the 6-bromohexyl side chain. These results revealed bromoalkoxyxanthones as interesting scaffolds to look for potential anticancer drugs.
Language: English
Type (Professor's evaluation): Scientific
Contact: esousa@ff.up.pt
No. of pages: 6
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Xanthenes in Medicinal Chemistry - Synthetic strategies and biological activities (2021)
Another Publication in an International Scientific Journal
Maia, M; Resende, DISP; Duraes, F; Pinto, MMM; Emilia Sousa
Tryptophan derived natural marine alkaloids and synthetic derivatives as promising antimicrobial agents (2021)
Another Publication in an International Scientific Journal
Almeida, MC; Resende, DISP; da Costa, PM; Pinto, MMM; Emilia Sousa
Quinoxaline, its derivatives and applications: A State of the Art review (2015)
Another Publication in an International Scientific Journal
Pereira, JA; Pessoa, AM; Natalia N D S Cordeiro; Fernandes, R; Prudencio, C; Noronha, JP; Vieira, M
Diarylpentanoids with antitumor activity: A critical review of structure-activity relationship studies (2020)
Another Publication in an International Scientific Journal
Moreira, J; Lucilia Saraiva; Pinto, MM; Honorina Cidade

See all (82)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-17 at 03:28:48 | Privacy Policy | Personal Data Protection Policy | Whistleblowing